98 related articles for article (PubMed ID: 9785338)
1. Guidelines for the use of rHuEpo in anaemia of malignancy. Department of Internal Medicine and Medical Therapy, University of Pavia Medical school, Pavia, Italy.
Med Oncol; 1998 Aug; 15 Suppl 1():S50. PubMed ID: 9785338
[No Abstract] [Full Text] [Related]
2. Recombinant human erythropoietin (rHuEPO) therapy in patients with cancer-related anaemia: what have we learned?
Osterborg A
Med Oncol; 1998 Aug; 15 Suppl 1():S47-9. PubMed ID: 9785337
[No Abstract] [Full Text] [Related]
3. Use of recombinant human erythropoietin in anemia of malignancy.
Cazzola M
Med Oncol; 1998 Aug; 15 Suppl 1():S1-2. PubMed ID: 9785329
[No Abstract] [Full Text] [Related]
4. Current thinking and treatment practices in anaemia--an interactive poll.
Spivak JL; Cazzola M
Med Oncol; 2000 Nov; 17 Suppl 1():S32-7. PubMed ID: 11188784
[TBL] [Abstract][Full Text] [Related]
5. Treatment of anaemia with rHuEpo in patients with MDS.
Casadevall N
Med Oncol; 1998 Aug; 15 Suppl 1():S35-7. PubMed ID: 9785335
[No Abstract] [Full Text] [Related]
6. [Use of human recombinant erythropoietin in children with cancer].
Guyot D; Margueritte G
Arch Pediatr; 2005 Sep; 12(9):1376-82. PubMed ID: 16084072
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin and its use in renal failure.
Sulková S; Krajhanzl A
EDTNA ERCA J; 1996; 22(1):suppl 1-7; quiz 8. PubMed ID: 10723310
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in clinical trials: assessment and utility with special reference to rHuEPO.
Brandberg Y
Med Oncol; 1998 Aug; 15 Suppl 1():S8-12. PubMed ID: 9785331
[No Abstract] [Full Text] [Related]
9. Alfa-epoietin and anaemia in gynaecological cancer.
Di Cocco B; Salesi N; Fabi A; Nardoni C; Ferretti G; Bossone G; Ciccarese M; Savarese A; Vecchione A; Cognetti F
Anticancer Res; 2004; 24(2C):1287-92. PubMed ID: 15154662
[TBL] [Abstract][Full Text] [Related]
10. [Clinical use of erythropoietin].
Franchini M; Gandini G; Lippi G; De Gironcoli M; Cantini M; Aprili G
Recenti Prog Med; 2004 Mar; 95(3):129-36; quiz 185. PubMed ID: 15143948
[TBL] [Abstract][Full Text] [Related]
11. [Summary version of the Standards, Options and Recommendations for the use of recombinant erythropoietin (epoietin-alpha and beta, darbepoietin-alpha, EPO) in the management of anaemia in oncology - Update 2003].
Spaeth D; Casadevall N; Daouphars M; Marchal C; Marec-Berard P; Fabre N; Haugh M;
Bull Cancer; 2004 Feb; 91(2):179-88. PubMed ID: 15047458
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Baron F; Frère P; Fillet G; Beguin Y
Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin.
Cazzola M
Med Oncol; 2000 Nov; 17 Suppl 1():S11-6. PubMed ID: 11188780
[TBL] [Abstract][Full Text] [Related]
14. [Human recombinant erythropoietin therapy].
Donato H; Ferro H
Medicina (B Aires); 2006; 66(1):51-69. PubMed ID: 16555732
[TBL] [Abstract][Full Text] [Related]
15. Assessing the impact of cancer-related anaemia on quality of life and the role of rHuEPO.
Brandberg Y
Med Oncol; 2000 Nov; 17 Suppl 1():S23-31. PubMed ID: 11188783
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin use in cancer patients: a matter of life and death?
Steensma DP; Loprinzi CL
J Clin Oncol; 2005 Sep; 23(25):5865-8. PubMed ID: 16087951
[No Abstract] [Full Text] [Related]
17. [Pure red cell aplasia in erythropoietin therapy in patients with kidney failure].
Opatrný K
Cas Lek Cesk; 2003; 142(12):741-5. PubMed ID: 14746223
[TBL] [Abstract][Full Text] [Related]
18. NCCN: New applications for erythropoietin.
Demetri GD
Cancer Control; 2001; 8(6 Suppl 2):72-6. PubMed ID: 11760562
[No Abstract] [Full Text] [Related]
19. Successful treatment of anaemia of nephrotic syndrome with recombinant human erythropoietin.
Bayés B; Serra A; Juncà J; Lauzurica R
Nephrol Dial Transplant; 1998 Jul; 13(7):1894-5. PubMed ID: 9681764
[No Abstract] [Full Text] [Related]
20. Erythropoietin therapy: need for rationality and active surveillance.
Cazzola M
Haematologica; 2003 Jun; 88(6):601-5. PubMed ID: 12801832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
